BS42 How warfarin and antiplatelets affect clot structure in atrial fibrillation

Introduction

Atrial fibrillation (AF) and coronary artery disease (CAD) are two common cardiovascular conditions associated with increased morbidity and mortality. Both conditions bring a risk of thrombosis and thus antithrombotic therapy is indicated. Despite recognised treatment, stroke and myocardial infarctions still occur. Accordingly, the identification of patients whose haemostasis remains unimpaired by treatment is valuable....